Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fortis put 'on watch...

    Fortis put 'on watch under implications' by ICRA

    Written by Geeta Sharma Sharma Published On 2016-06-24T20:52:19+05:30  |  Updated On 23 Dec 2022 12:29 PM IST
    Fortis put on watch under implications by ICRA
    Mumbai: Fortis Healthcare's A+ instruments- a 250 crore NCD programme and another 200 crore fund base limits have been put 'on watch under implications' by the Indian Credit Rating limited. This comes after the Rs 503 crore penalty imposition by the government on Escorts Heart Institute and Research Centre Ltd (EHIRCL). EHIRCL is a subsidiary of the Fortis hospital chain.

    The fine imposition by the government was a result of violation of land agreement, wherein limited free treatment, was to be provided to poorer patients.The
    penalty
    that was related to 'unwarranted profits' is to be submitted by July 9.

    On June 10 Fortis Healthcare in a BSE filing had stated that its subsidiary,Escort Heart Institute and Research Centre (EHIRCL) had received an order from the Directorate General of Health Services (DHS) to deposit Rs 503.36 crore for non-compliance of conditions of land allotment lease.

    However, the company had then stated that it would challenge the order for the recovery of 'unwarranted profit' made by Escorts, not following conditions of land lease, since its allotment in 1982.

    "EHIRCL has informed us that in a long disputed case pertaining to the period 1984-2007, it has today received an order from DHS for the deposit of an amount of Rs 503.36 crore towards recovery of unwarranted profit made by it for alleged non-compliance of the conditions of allotment/lease of land since its allotment in its allotment in 1982," Fortis Healthcare said in a BSE filing.

    'EHIRCL has further informed that the impugned order in its view is legally flawed and untenable,' the company added.

    This Wednesday, Fortis shares closed down 1.32 per cent at Rs.160.80 on the BSE, reports Hindu's Business line. This has happened because of the the 'On watch under implications' status granted by ICRA to Fortis healthcare.

    Malvinder Singh and Shivinder Singh, the two brothers own a 72% stake in Fortis Healthcare. Fortis is a nationwide chain of 54 hospitals.
    EHIRCLEscorts Heart Institute and Research CentreFortis HealthcareICRAIndian credit rating agencyMalvinder SinghOn WatchShivinder Singh
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok